share_log

賽生藥業：股東週年大會通告

SCICLONE PHARMA: NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 29 04:39
Summary by Moomoo AI
赛生药业控股有限公司宣布將於2024年6月28日在上海舉行股東週年大會，會議將審議包括審核2023年度經審計財務報表、董事及核數師報告，以及重選董事和核數師等事宜。此外，大會將考慮授權董事會購回及發行股份，並修訂公司章程細則。股東將對所有決議案進行投票，並可委派代表出席投票。公司股份過戶登記將於2024年6月25日至28日暫停，以確定出席及投票資格。
赛生药业控股有限公司宣布將於2024年6月28日在上海舉行股東週年大會，會議將審議包括審核2023年度經審計財務報表、董事及核數師報告，以及重選董事和核數師等事宜。此外，大會將考慮授權董事會購回及發行股份，並修訂公司章程細則。股東將對所有決議案進行投票，並可委派代表出席投票。公司股份過戶登記將於2024年6月25日至28日暫停，以確定出席及投票資格。
SAI SANG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED THAT IT WILL HOLD ITS ANNUAL GENERAL MEETING IN SHANGHAI ON 28 JUNE 2024, WHICH WILL INCLUDE AUDITING OF AUDITED FINANCIAL STATEMENTS FOR 2023, REPORTS OF DIRECTORS AND AUDITORS, AND RE-ELECTION OF DIRECTORS AND AUDITORS. In addition, the General Meeting will consider authorizing the Board to repurchase and issue shares and to amend the Articles of Association. Shareholders will vote on all resolutions and may appoint representatives to vote. The registration of the Company's shares will be suspended from 25 to 28 June 2024 to determine attendance and voting eligibility.
SAI SANG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED THAT IT WILL HOLD ITS ANNUAL GENERAL MEETING IN SHANGHAI ON 28 JUNE 2024, WHICH WILL INCLUDE AUDITING OF AUDITED FINANCIAL STATEMENTS FOR 2023, REPORTS OF DIRECTORS AND AUDITORS, AND RE-ELECTION OF DIRECTORS AND AUDITORS. In addition, the General Meeting will consider authorizing the Board to repurchase and issue shares and to amend the Articles of Association. Shareholders will vote on all resolutions and may appoint representatives to vote. The registration of the Company's shares will be suspended from 25 to 28 June 2024 to determine attendance and voting eligibility.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more